Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Galectins”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Not applicableLooking for participantsNCT04160455
What this trial is testing

Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

Who this might be right for
AutophagyGalectinsHIV Infections+1 more
Centre Hospitalier Régional d'Orléans 180
Large-scale testing (Phase 3)UnknownNCT05935423
What this trial is testing

Umbilical Cord Mesenchymal Stem Cell Improve Cardiac Function on ST-elevation Myocardial Infarction (STEMI) Patients

Who this might be right for
ST Elevation Myocardial Infarction
Indonesia University 60
Not applicableUnknownNCT05054556
What this trial is testing

Galectin and Respiratory Weaning

Who this might be right for
Galectin-3 During Respiratory Weaning
Asklepios Neurological Clinic Bad Salzhausen 150
Testing effectiveness (Phase 2)UnknownNCT05009680
What this trial is testing

A Single and Repeat Dose Trial in Participants With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Galecto Biotech AB 54
Not applicableStudy completedNCT06038812
What this trial is testing

Galectin Role in Periodontal Disease

Who this might be right for
GingivitisPeriodontitis
Fayoum University 45
Early research (Phase 1)Study completedNCT02575404
What this trial is testing

GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients

Who this might be right for
MelanomaNon-Small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Providence Health & Services 36
Not applicableStudy completedNCT07341893
What this trial is testing

Sacubitril-valsartan in Patients With Heart Failure.

Who this might be right for
Heart Failure
Damanhour University 60
Not applicableUnknownNCT04401592
What this trial is testing

The Role of Galectins in the Non-invasive Diagnosis of Endometriosis

Who this might be right for
EndometriosisEndometriosis OvaryEndometriosis Rectovaginal Septum
Semmelweis University 1,000
Not applicableUnknownNCT06430450
What this trial is testing

Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin 3, IL-4, IL-10 and TNF-α Levels in Individuals With Different Degrees of Periodontal Disease

Who this might be right for
PeriodontitisPeriodontal Diseases
Karamanoğlu Mehmetbey University 80
Testing effectiveness (Phase 2)Study completedNCT06398821
What this trial is testing

G3P-01 in Volunteers With Elevated Galectin-3

Who this might be right for
Galectin 3Healthy Aging
General Practitioners Research Institute 48
Not applicableUnknownNCT02804321
What this trial is testing

Plasma Aldosterone Levels and Atrial Fibrillation Reduction (ALDO-AF Study)

Who this might be right for
Atrial FibrillationAldosterone
University Hospital, Caen 170
Early research (Phase 1)Study completedNCT02117362
What this trial is testing

Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Providence Health & Services 8
Early research (Phase 1)UnknownNCT01724320
What this trial is testing

A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 20
Not applicableLooking for participantsNCT04014647
What this trial is testing

Measurement Of NT-proBNP to Predict Outcomes in Surgery

Who this might be right for
Vascular Surgical Procedure
Norfolk and Norwich University Hospitals NHS Foundation Trust 200
Not applicableUnknownNCT05992727
What this trial is testing

Evaluation of Galectin-3 in Serum and Saliva of Pemphigus Patients

Who this might be right for
Galectin-3 and Pemphigus
Assiut University 60
Large-scale testing (Phase 3)UnknownNCT05096052
What this trial is testing

PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19

Who this might be right for
COVID-19COVID-19 PandemicCOVID-19 Respiratory Infection+2 more
Bioxytran Inc. 408
Testing effectiveness (Phase 2)WithdrawnNCT04987996
What this trial is testing

GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients

Who this might be right for
Metastatic MelanomaHead and Neck Squamous Cell Carcinoma
Providence Health & Services
Not applicableStudy completedNCT01960946
What this trial is testing

Galectin-3 Blockade in Patients With High Blood Pressure

Who this might be right for
Hypertension
Massachusetts General Hospital 59
Not applicableStudy completedNCT01588288
What this trial is testing

Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter

Who this might be right for
Goiter, Nodular
University Hospital, Rouen 193